Artículos del autor

solaci

Structural heart disease

NOTION: 5-Year Outcomes of TAVR vs. Surgery in Low-Risk Patients are Promising

At 5 years, there were no differences in all-cause death, stroke, acute myocardial infarction, or all of these...
solaci -
Structural heart disease

Permanent Pacemaker: still TAVR’s Aquila’s Heel

TAVR has shown benefits in high risk patients (prohibitive) and in intermediate risk patients, but the need for permanent...
solaci -
ACC 2018

ACC 2018

Here you will find the highlights of the ACC 2018, held on March 10-12 in the city...
solaci -
Antiplatelet

Dual Antiplatelet Therapy: Less Is More for Elderly Patients

A recent meta-analysis that will be published soon in JACC Intv offers evidence of benefit derived from...
solaci -
Antiplatelet

Transulnar Access: Another Ace Up Our Sleeve Before Transfemoral Access

Transulnar access can be as safe and effective as transradial access, and it is a particularly good...
solaci -
Acute coronary syndromes

Tips to Prevent Radial Occlusion after Catheterization

The transradial access is the preferred access site for patients undergoing acute coronary syndrome. Compared to the transfemoral access site,...
solaci -
Chronic Ischemic cardiopathy

Surgery Seems Superior to Angioplasty in Young Patients

Long-term follow-up of patients under 50 with multivessel coronary artery disease suggests surgery outcomes are significantly better...
solaci -
Antiplatelet

New Study Shows Ticagrelor + Aspirin Reduce Events Rate

Just when we were starting to understand how long dual antiplatelet therapy should be for our patients, JACC publishes...
solaci -